Prices as of 2026/10/30 close
Company comparison · Café & Bakery-Café Chains
Doutor Nichires is the bigger company, with revenue of ¥159.1B — 2.8x Komeda's ¥57.2B.
Komeda earns more on each yen of sales, with an operating margin of 16.5% — 10.1 points above Doutor Nichires (6.4%).
Revenue growth in the latest results: Komeda +21.6%, Doutor Nichires +6.9%. For next year, Doutor Nichires guides for the fastest operating profit growth (+8.8%).
Over the past year the shares moved Doutor Nichires +49.7%, Komeda +2.6%.
Head-to-head wins14 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
Doutor Nichires aheadDoutor Nichires 3 : Komeda 0
Revenue: Doutor Nichires ¥159.1B / Komeda ¥57.2B
ProfitabilityInvestors
Komeda aheadDoutor Nichires 0 : Komeda 3
Operating margin: Doutor Nichires 6.4% / Komeda 16.5%
GrowthInvestors
Komeda aheadDoutor Nichires 1 : Komeda 3
Revenue growth (YoY): Doutor Nichires +6.9% / Komeda +21.6%
Stock & balance sheetInvestors
Doutor Nichires aheadDoutor Nichires 3 : Komeda 0
Share price, 1 year: Doutor Nichires +49.7% / Komeda +2.6%
Pay & workforceJob seekers
Komeda aheadDoutor Nichires 0 : Komeda 1
Average tenure: Doutor Nichires 9.3 yrs / Komeda 9.7 yrs
| Metric | Doutor Nichires | Komeda | Gap |
|---|---|---|---|
| Revenue | ◎¥159.1B | ¥57.2B | 2.8x |
| Operating profit | ◎¥10.2B | ¥9.4B | 1.1x |
| Net income | ◎¥7.2B | ¥6.5B | 1.1x |
| Metric | Doutor Nichires | Komeda | Gap |
|---|---|---|---|
| Operating margin | 6.4% | ◎16.5% | 10.1pt |
| Net margin | 4.5% | ◎11.3% | 6.7pt |
| ROE | 6.9% | ◎13.5% | 6.6pt |
| Metric | Doutor Nichires | Komeda | Gap |
|---|---|---|---|
| Revenue growth (YoY) | +6.9% | ◎+21.6% | 14.7pt |
| Operating profit growth (YoY) | +5.8% | ◎+6.8% | 1.0pt |
| Guidance: revenue growthnext FY plan | +4.6% | ◎+6.5% | 1.8pt |
| Guidance: op. profit growthnext FY plan | ◎+8.8% | +8.2% | 0.6pt |
| Metric | Doutor Nichires | Komeda | Gap |
|---|---|---|---|
| Share price, 1 year | ◎+49.7% | +2.6% | 47.1pt |
| Share price, 3 months | ◎+7.9% | −0.1% | 8.0pt |
| P/E (trailing)lower = cheaper | 20.9x | 20.9x | |
| Equity ratio | ◎77.3% | 45.4% | 31.9pt |
| Share price (close) | ¥3,565 | ¥2,962 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | Doutor Nichires | Komeda | Gap |
|---|---|---|---|
| Starting salary (monthly) | — | ¥219,000 | |
| Average tenure | 9.3 yrs | ◎9.7 yrs | 0.4 |
| Average age | 43.4 | 52.0 | 8.6 |
| Employees | 22 | 6 | 3.7x |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥3,565+49.7% (1Y)
Doutor Nichires +49.7% over 1Y. Compared: Komeda +2.6%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
ARevenue in the latest results: Doutor Nichires ¥159.1B, Komeda ¥57.2B. Doutor Nichires is the bigger company, with revenue of ¥159.1B — 2.8x Komeda's ¥57.2B.
AOperating margins: Komeda 16.5%, Doutor Nichires 6.4%. Komeda turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): Doutor Nichires +49.7%, Komeda +2.6%. Doutor Nichires has risen the most.
Comparing 2 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.
